In pursuit of female Viagra

‘Female Viagra‘? No such thing. There is a warmed up leftover reject of a failed antidepressant drug named flibabserin – reborn with the new name “Addyi”. But, the redubbed Addyi failed so badly as a female arousal drug in study trials that it only “improved” female sex desire by a measly 0.3 points on a 6-point scale when compared to a placebo. Furthermore, while a meager 10% of females actually reported any benefits at all, 15% of women had to quit the trial cold-turkey with nausea, dizziness, low blood pressure and other extreme side effects. Heck, this drug is even linked to causing cancer! So, how in hell’s damned creation did this ludicrous progeny of Satan make recent FDA muster? Uh, media frenzy and “public demand” spawned by a Big Pharma campaign of “women’s rights activists” (bought and paid for by the same benevolent company that makes the drug). If you can read this, then you can see that FDA must stand for Fraud, Deception and Amorality as the agency flippantly signs off on an evil drug that Falsely Dupes Americans into Fetish Driven Absurdity. It is high-time to tell the FDA to Forthwith Desist and Abdicate. Don’t EVEN git me started…

It's a deal with the devil!

It’s a deal with the devil!

About Craig Stellpflug NDC

Craig Stellpflug is a NeuroDevelopment Consultant and a Certified Nutritional Consultant. Craig is a cancer nutritionist and child brain disorder specialist at Healing Pathways Medical Clinic in Scottsdale Arizona.
This entry was posted in Medical Madness and tagged , , , , , , . Bookmark the permalink.

Leave a Reply